Compare CLPS & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPS | NAII |
|---|---|---|
| Founded | 2005 | 1980 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 21.2M |
| IPO Year | 2018 | 1987 |
| Metric | CLPS | NAII |
|---|---|---|
| Price | $0.85 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.4K | ★ 20.2K |
| Earning Date | 10-17-2025 | 11-12-2025 |
| Dividend Yield | ★ 15.38% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $164,481,414.00 | $134,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 15.17 | ★ 19.00 |
| 52 Week Low | $0.82 | $2.57 |
| 52 Week High | $1.88 | $4.40 |
| Indicator | CLPS | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 46.82 |
| Support Level | $0.84 | $3.11 |
| Resistance Level | $0.90 | $3.33 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 4.44 | 12.50 |
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.